Anti-Granzyme B/GZMB antibody

Cat.#: 101748

Special Price 145.0 USD

Availability: In Stock
- +

Add to cart to get an online quotation

Product Information

  • Product Name
    Anti-Granzyme B/GZMB antibody
  • Documents
  • Description
    Mouse monoclonal to Granzyme B/GZMB
  • Tested applications
    ELISA, IHC-P
  • Species reactivity
    Human Granzyme B / GZMB
  • Alternative names
    CCP1 antibody; HLP antibody; CCPI antibody; CGL1 antibody; CSPB antibody; SECT antibody; CGL-1 antibody; CSP-B antibody; CTLA1 antibody; CTSGL1 antibody; GZB antibody; Ctla1 antibody; Ctla-1 antibody; AI553453 antibody; CCP-1/C11 antibody; AI553453 antibody; CCP1 antibody; CCP-1/C11 antibody; CCPI antibody; CGL1 antibody; CGL-1 antibody; CSPB antibody; CSP-B antibody; Ctla1 antibody; CTLA1 antibody; Ctla-1 antibody; CTSGL1 antibody; Gamb antibody; Granzyme B antibody; Granzyme B antibody; GZB antibody; GZMB antibody; HLP antibody; SECT antibody
  • Immunogen
  • Isotype
    Mouse IgG2b
  • Preparation
    This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human Granzyme B (rhGranzyme B; NP_004122.1; Met 1-Tyr 247). The IgG fraction of the cell culture supernatant was purified by Protein A affinity chromatography.
  • Clonality
    Monoclonal
  • Formulation
    0.2 μm filtered solution in PBS with 5% trehalose
  • Storage instructions
    This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free.
    Sodium azide is recommended to avoid contamination (final concentration 0.05%-0.1%). It is toxic to cells and should be disposed of properly. Avoid repeated freeze-thaw cycles.
  • Applications

    ELISA: 0.5-1 μg/mL

    This antibody can be used at 0.5-1 μg/mL with the appropriate secondary reagents to detect Human Granzyme B. The detection limit for Human Granzyme B is approximately 10 ng/well.

    IHC-P: 10-30 μg/mL

  • Validations

    Granzyme B / GZMB Antibody, Mouse MAb, Immunohistochemistry

    Granzyme B / GZMB Antibody, Mouse MAb, Immunohistochemistry

    Immunochemical staining of human Granzyme B in human lymph node with mouse monoclonal antibody (15µg/mL, formalin-fixed paraffin embedded sections).

    Granzyme B / GZMB Antibody, Mouse MAb, Immunohistochemistry

    Granzyme B / GZMB Antibody, Mouse MAb, Immunohistochemistry

    Immunochemical staining of human Granzyme B in human spleen with mouse monoclonal antibody (15µg/mL, formalin-fixed paraffin embedded sections).

    Granzyme B / GZMB Antibody, Mouse MAb, Immunohistochemistry

    Granzyme B / GZMB Antibody, Mouse MAb, Immunohistochemistry

    Immunochemical staining of human Granzyme B in human tonsil with mouse monoclonal antibody (15µg/mL, formalin-fixed paraffin embedded sections).

  • Background
    Granzyme B, also known as GZMB, is the most prominent member of the granzyme family of cell death-inducing serine proteases expressed in the granules of cytotoxic T lymphocytes (CTLs) and NK cells. Granzyme B enters the target cells depending on another membrane-binding granule protein, perforin, results in the activation of effector caspases and mitochondrial depolarization through caspase-dependent and -independent pathways, and consequently induces rapid cell apoptosis. Over 30 substrates of GZMB have been identified including the key substrate caspase-3, ICAD and Bid. GZMB is suggested to protect the host by lysing cells bearing on their surface 'nonself' antigens such as bacterial and viral infected-cells and tumor cells, and accordingly plays an essential role in immunosurveillance.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"